100 related articles for article (PubMed ID: 29458013)
1. Argonaute 2 RNA Immunoprecipitation Reveals Distinct miRNA Targetomes of Primary Burkitt Lymphoma Tumors and Normal B Cells.
Dzikiewicz-Krawczyk A; Diepstra A; Rutgers B; Kortman G; de Jong D; Koerts J; Bulthuis M; van der Sluis T; Seitz A; Visser L; Kok K; Kluiver J; van den Berg A
Am J Pathol; 2018 May; 188(5):1289-1299. PubMed ID: 29458013
[TBL] [Abstract][Full Text] [Related]
2. B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression.
Leucci E; Onnis A; Cocco M; De Falco G; Imperatore F; Giuseppina A; Costanzo V; Cerino G; Mannucci S; Cantisani R; Nyagol J; Mwanda W; Iriso R; Owang M; Schurfeld K; Bellan C; Lazzi S; Leoncini L
Int J Cancer; 2010 Mar; 126(6):1316-26. PubMed ID: 19530237
[TBL] [Abstract][Full Text] [Related]
3. Identification of transforming growth factor-beta-regulated microRNAs and the microRNA-targetomes in primary lung fibroblasts.
Ong J; Timens W; Rajendran V; Algra A; Spira A; Lenburg ME; Campbell JD; van den Berge M; Postma DS; van den Berg A; Kluiver J; Brandsma CA
PLoS One; 2017; 12(9):e0183815. PubMed ID: 28910321
[TBL] [Abstract][Full Text] [Related]
4. Low expression of miR-150 in pediatric intestinal Burkitt lymphoma.
Wang M; Yang W; Li M; Li Y
Exp Mol Pathol; 2014 Apr; 96(2):261-6. PubMed ID: 24613688
[TBL] [Abstract][Full Text] [Related]
5. Integrative microRNA and mRNA deep-sequencing expression profiling in endemic Burkitt lymphoma.
Oduor CI; Kaymaz Y; Chelimo K; Otieno JA; Ong'echa JM; Moormann AM; Bailey JA
BMC Cancer; 2017 Nov; 17(1):761. PubMed ID: 29132323
[TBL] [Abstract][Full Text] [Related]
6. Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma.
Kluiver J; Haralambieva E; de Jong D; Blokzijl T; Jacobs S; Kroesen BJ; Poppema S; van den Berg A
Genes Chromosomes Cancer; 2006 Feb; 45(2):147-53. PubMed ID: 16235244
[TBL] [Abstract][Full Text] [Related]
7. MiR-378a-3p Is Critical for Burkitt Lymphoma Cell Growth.
Niu F; Dzikiewicz-Krawczyk A; Koerts J; de Jong D; Wijenberg L; Fernandez Hernandez M; Slezak-Prochazka I; Winkle M; Kooistra W; van der Sluis T; Rutgers B; Terpstra MM; Kok K; Kluiver J; van den Berg A
Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33261009
[TBL] [Abstract][Full Text] [Related]
8. The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma.
Lenze D; Leoncini L; Hummel M; Volinia S; Liu CG; Amato T; De Falco G; Githanga J; Horn H; Nyagol J; Ott G; Palatini J; Pfreundschuh M; Rogena E; Rosenwald A; Siebert R; Croce CM; Stein H
Leukemia; 2011 Dec; 25(12):1869-1876. PubMed ID: 21701491
[TBL] [Abstract][Full Text] [Related]
9. Screening for possible miRNA-mRNA associations in a colon cancer cell line.
Kanematsu S; Tanimoto K; Suzuki Y; Sugano S
Gene; 2014 Jan; 533(2):520-31. PubMed ID: 23939471
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide identification of translationally inhibited and degraded miR-155 targets using RNA-interacting protein-IP.
Meier J; Hovestadt V; Zapatka M; Pscherer A; Lichter P; Seiffert M
RNA Biol; 2013 Jun; 10(6):1018-29. PubMed ID: 23673373
[TBL] [Abstract][Full Text] [Related]
11. FAMLF is a target of miR-181b in Burkitt lymphoma.
Li JG; Ding Y; Huang YM; Chen WL; Pan LL; Li Y; Chen XL; Chen Y; Wang SY; Wu XN
Braz J Med Biol Res; 2017 May; 50(6):e5661. PubMed ID: 28492808
[TBL] [Abstract][Full Text] [Related]
12. MiR-29 silencing modulates the expression of target genes related to proliferation, apoptosis and methylation in Burkitt lymphoma cells.
Mazzoccoli L; Robaina MC; Apa AG; Bonamino M; Pinto LW; Queiroga E; Bacchi CE; Klumb CE
J Cancer Res Clin Oncol; 2018 Mar; 144(3):483-497. PubMed ID: 29318382
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the miR-155 target NIAM phenocopies the growth promoting effect of miR-155 in B-cell lymphoma.
Slezak-Prochazka I; Kluiver J; de Jong D; Smigielska-Czepiel K; Kortman G; Winkle M; Rutgers B; Koerts J; Visser L; Diepstra A; Kroesen BJ; van den Berg A
Oncotarget; 2016 Jan; 7(3):2391-400. PubMed ID: 26497687
[TBL] [Abstract][Full Text] [Related]
14. Alteration of microRNAs regulated by c-Myc in Burkitt lymphoma.
Onnis A; De Falco G; Antonicelli G; Onorati M; Bellan C; Sherman O; Sayed S; Leoncini L
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20930934
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA High Throughput Loss-of-Function Screening Reveals an Oncogenic Role for miR-21-5p in Hodgkin Lymphoma.
Yuan Y; Niu F; Nolte IM; Koerts J; de Jong D; Rutgers B; Osinga J; Azkanaz M; Terpstra M; Bystrykh L; Diepstra A; Visser L; Dzikiewicz-Krawczyk A; Kok K; Kluiver J; van den Berg A
Cell Physiol Biochem; 2018; 49(1):144-159. PubMed ID: 30184526
[TBL] [Abstract][Full Text] [Related]
16. miR-17-92 cluster components analysis in Burkitt lymphoma: overexpression of miR-17 is associated with poor prognosis.
Robaina MC; Faccion RS; Mazzoccoli L; Rezende LM; Queiroga E; Bacchi CE; Thomas-Tikhonenko A; Klumb CE
Ann Hematol; 2016 May; 95(6):881-91. PubMed ID: 27044389
[TBL] [Abstract][Full Text] [Related]
17. MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation.
Leucci E; Cocco M; Onnis A; De Falco G; van Cleef P; Bellan C; van Rijk A; Nyagol J; Byakika B; Lazzi S; Tosi P; van Krieken H; Leoncini L
J Pathol; 2008 Dec; 216(4):440-50. PubMed ID: 18802929
[TBL] [Abstract][Full Text] [Related]
18. The miR-26b-5p/KPNA2 Axis Is an Important Regulator of Burkitt Lymphoma Cell Growth.
Niu F; Kazimierska M; Nolte IM; Terpstra MM; de Jong D; Koerts J; van der Sluis T; Rutgers B; O'Connell RM; Kok K; van den Berg A; Dzikiewicz-Krawczyk A; Kluiver J
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32512858
[TBL] [Abstract][Full Text] [Related]
19. Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes.
Cinti C; Leoncini L; Nyongo A; Ferrari F; Lazzi S; Bellan C; Vatti R; Zamparelli A; Cevenini G; Tosi GM; Claudio PP; Maraldi NM; Tosi P; Giordano A
Am J Pathol; 2000 Mar; 156(3):751-60. PubMed ID: 10702389
[TBL] [Abstract][Full Text] [Related]
20. miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B-cell lymphoma.
Zajdel M; Rymkiewicz G; Chechlinska M; Blachnio K; Pienkowska-Grela B; Grygalewicz B; Goryca K; Cieslikowska M; Bystydzienski Z; Swoboda P; Walewski J; Siwicki JK
Tumour Biol; 2015 Jul; 36(7):5377-88. PubMed ID: 25677902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
